Simulations Plus (NASDAQ:SLP) Issues Earnings Results

Simulations Plus (NASDAQ:SLP) issued its quarterly earnings data on Tuesday. The technology company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.15 by $0.04, Briefing.com reports. The business had revenue of $18.54 million during the quarter, compared to analyst estimates of $17.92 million. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. The company’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.20 EPS. Simulations Plus updated its FY24 guidance to $0.54-0.56 EPS and its FY 2024 guidance to 0.540-0.560 EPS.

Simulations Plus Price Performance

Shares of NASDAQ:SLP traded down $6.97 during midday trading on Thursday, hitting $39.89. The company had a trading volume of 340,703 shares, compared to its average volume of 109,728. Simulations Plus has a 12-month low of $32.69 and a 12-month high of $52.69. The company has a fifty day moving average of $47.68 and a two-hundred day moving average of $44.15. The company has a market cap of $797.40 million, a price-to-earnings ratio of 75.26 and a beta of 0.72.

Simulations Plus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 5th. Stockholders of record on Monday, July 29th will be paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend is Monday, July 29th. Simulations Plus’s dividend payout ratio is presently 45.28%.

Analyst Upgrades and Downgrades

Several analysts have commented on SLP shares. William Blair initiated coverage on shares of Simulations Plus in a report on Friday, June 28th. They issued an “outperform” rating for the company. Oppenheimer increased their price target on shares of Simulations Plus from $55.00 to $65.00 and gave the stock an “outperform” rating in a research note on Thursday, June 13th. Finally, Craig Hallum reissued a “buy” rating and issued a $56.00 price target on shares of Simulations Plus in a research report on Wednesday.

Insider Activity at Simulations Plus

In other news, Director Daniel L. Weiner sold 750 shares of Simulations Plus stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $49.32, for a total transaction of $36,990.00. Following the transaction, the director now directly owns 7,009 shares of the company’s stock, valued at approximately $345,683.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Daniel L. Weiner sold 3,250 shares of Simulations Plus stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $48.31, for a total transaction of $157,007.50. Following the transaction, the director now directly owns 8,759 shares of the company’s stock, valued at approximately $423,147.29. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Daniel L. Weiner sold 750 shares of Simulations Plus stock in a transaction dated Friday, June 28th. The shares were sold at an average price of $49.32, for a total value of $36,990.00. Following the transaction, the director now directly owns 7,009 shares in the company, valued at $345,683.88. The disclosure for this sale can be found here. Over the last three months, insiders have sold 44,500 shares of company stock worth $2,072,198. Corporate insiders own 20.90% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.